U.S. markets close in 3 hours 54 minutes
  • S&P 500

    3,838.25
    +8.91 (+0.23%)
     
  • Dow 30

    31,156.97
    -245.04 (-0.78%)
     
  • Nasdaq

    13,275.49
    +156.05 (+1.19%)
     
  • Russell 2000

    2,207.15
    +6.98 (+0.32%)
     
  • Crude Oil

    62.18
    -1.35 (-2.12%)
     
  • Gold

    1,717.40
    -58.00 (-3.27%)
     
  • Silver

    26.26
    -1.42 (-5.13%)
     
  • EUR/USD

    1.2089
    -0.0097 (-0.80%)
     
  • 10-Yr Bond

    1.5010
    -0.0170 (-1.12%)
     
  • GBP/USD

    1.3936
    -0.0077 (-0.55%)
     
  • USD/JPY

    106.6600
    +0.4300 (+0.40%)
     
  • BTC-USD

    48,370.79
    -2,466.83 (-4.85%)
     
  • CMC Crypto 200

    970.58
    +37.44 (+4.01%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

Vanda: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported fourth-quarter profit of $8.2 million.

The Washington-based company said it had net income of 15 cents per share.

The biopharmaceutical company posted revenue of $67.7 million in the period.

For the year, the company reported profit of $23.3 million, or 42 cents per share. Revenue was reported as $248.2 million.

Vanda expects full-year revenue in the range of $270 million to $300 million.

Vanda shares have risen 17% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $15.41, a rise of 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA